These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 2672252)

  • 1. Use of the new quinolones in cystic fibrosis.
    Grenier B
    Rev Infect Dis; 1989; 11 Suppl 5():S1245-52. PubMed ID: 2672252
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical utility of new quinolones in treatment of osteomyelitis and lower respiratory tract infections.
    Bayer AS
    Eur J Clin Microbiol Infect Dis; 1989 Dec; 8(12):1102-10. PubMed ID: 2695331
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of quinolones in pediatrics.
    Schaad UB
    Eur J Clin Microbiol Infect Dis; 1991 Apr; 10(4):355-60. PubMed ID: 1864297
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antimicrobials in cystic fibrosis: emergence of resistance and implications for treatment.
    Zabner R; Quinn JP
    Semin Respir Infect; 1992 Sep; 7(3):210-7. PubMed ID: 1475544
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Fluoroquinolones: pharmacology, antibacterial spectrum and indications in pneumology].
    Underner M; Grignon B; Roblot F; Meurice JC; Patte F
    Rev Pneumol Clin; 1989; 45(1):14-22. PubMed ID: 2662344
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quinolones in the treatment of lower respiratory tract infections.
    Thys JP; Jacobs F; Motte S
    Rev Infect Dis; 1989; 11 Suppl 5():S1212-9. PubMed ID: 2672250
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sequential ciprofloxacin therapy in pediatric cystic fibrosis: comparative study vs. ceftazidime/tobramycin in the treatment of acute pulmonary exacerbations. The Cystic Fibrosis Study Group.
    Church DA; Kanga JF; Kuhn RJ; Rubio TT; Spohn WA; Stevens JC; Painter BG; Thurberg BE; Haverstock DC; Perroncel RY; Echols RM
    Pediatr Infect Dis J; 1997 Jan; 16(1):97-105; discussion 123-6. PubMed ID: 9002118
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fluoroquinolones in the treatment of cystic fibrosis: a critical appraisal.
    LeBel M
    Eur J Clin Microbiol Infect Dis; 1991 Apr; 10(4):316-24. PubMed ID: 1907546
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potential role of fluoroquinolones in pediatric infections.
    Douidar SM; Snodgrass WR
    Rev Infect Dis; 1989; 11(6):878-89. PubMed ID: 2513628
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Optimisation of antibiotic therapy in cystic fibrosis patients. Pharmacokinetic considerations.
    Lindsay CA; Bosso JA
    Clin Pharmacokinet; 1993 Jun; 24(6):496-506. PubMed ID: 8513651
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fluoroquinolones in the treatment of bronchopulmonary disease in cystic fibrosis.
    Hurley M; Smyth A
    Ther Adv Respir Dis; 2012 Dec; 6(6):363-73. PubMed ID: 22968160
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fluoroquinolone antibiotics. Microbiology, pharmacokinetics and clinical use.
    Paton JH; Reeves DS
    Drugs; 1988 Aug; 36(2):193-228. PubMed ID: 3053126
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The pharmacokinetics and tissue penetration of the fluoroquinolones.
    Bergeron MG
    Clin Invest Med; 1989 Feb; 12(1):20-7. PubMed ID: 2920479
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of the quinolones in paediatrics.
    Schaad UB
    Drugs; 1993; 45 Suppl 3():37-41. PubMed ID: 7689449
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Maintenance treatment with antibiotics in cystic fibrosis patients. Sense or nonsense?
    Hodson ME
    Neth J Med; 1995 Jun; 46(6):288-92. PubMed ID: 7643944
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fluoroquinolones in respiratory infections.
    Klein NC
    Semin Respir Infect; 1991 Sep; 6(3):131-5. PubMed ID: 1754733
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Once-daily versus multiple-daily dosing with intravenous aminoglycosides for cystic fibrosis.
    Smyth AR; Tan KH
    Cochrane Database Syst Rev; 2006 Jul; (3):CD002009. PubMed ID: 16855982
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Once daily versus multiple daily dosing with intravenous aminoglycosides for cystic fibrosis.
    Tan K; Bunn H
    Cochrane Database Syst Rev; 2000; (4):CD002009. PubMed ID: 11034740
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ciprofloxacin-induced acute renal failure in a patient with cystic fibrosis.
    Bald M; Ratjen F; Nikolaizik W; Wingen AM
    Pediatr Infect Dis J; 2001 Mar; 20(3):320-1. PubMed ID: 11303842
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetic disposition of sequential intravenous/oral ciprofloxacin in pediatric cystic fibrosis patients with acute pulmonary exacerbation.
    Rubio TT; Miles MV; Lettieri JT; Kuhn RJ; Echols RM; Church DA
    Pediatr Infect Dis J; 1997 Jan; 16(1):112-7; discussion 123-6. PubMed ID: 9002120
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.